MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
Brigham and Women's Hospital
Boston, Estados UnidosPublications in collaboration with researchers from Brigham and Women's Hospital (6)
2019
-
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia
Blood, Vol. 134, Núm. 12, pp. 951-959
2017
-
Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia
Blood Advances, Vol. 1, Núm. 21, pp. 1807-1814
-
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Blood, Vol. 129, Núm. 4, pp. 424-447
2015
-
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: A matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
Annals of Hematology, Vol. 94, Núm. 8, pp. 1347-1356
-
High Δnp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia
Blood, Vol. 126, Núm. 20, pp. 2302-2306
2013
-
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
Blood, Vol. 121, Núm. 11, pp. 1935-1943